January 13, 2021
Article
Cannabis use and cannabinoids influence various immune disorders and treatments, mostly via CB2 regulation, according to a virtual session at the at the ASHP 2020 Midyear meeting.
January 05, 2021
The objective of the study was to evaluate the impact of the ambulatory care pharmacist intervention on A1C changes in patients with uncontrolled type 2 diabetes mellitus (T2DM) during a 2-year period at the diabetes education center.
Pharmacists play a key role in educating patients on risk factors for cervical and endometrial cancers and can assist with treatment decisions, and management of potential adverse effects in patients with these cancers.
December 31, 2020
Telehealth has been crucial in expanding access to naloxone, a lifesaving drug used to reverse the effects of an opioid overdose.
December 15, 2020
Under the 340B Prime Vendor Program, the Prime Vendor has several functions that it carries out to support stakeholders in operating and navigate the field so that they can effectively achieve lower 340B drug pricing for those who need it most.
Wearable technology and apps that monitor health and wellness have exploded in popularity and sophistication in recent years.
December 14, 2020
Delirium is a common syndrome experienced by patients with COVID-19 while being treated in the ICU, according to a session at the 2020 ASHP Midyear Clinical Meeting and Exhibition.
Monitoring outpatient prescribing patterns has been a major challenge for the Lifespan health system in Rhode Island, since it has over 1.5 million electronic prescriptions written annually.
December 11, 2020
There are compelling reasons to use sodium-glucose cotransporter-2 (SGLT2) inhibitors for the treatment of type 2 diabetes, according to a session at the 2020 ASHP Midyear Clinical Meeting and Exhibition.
Inhalation therapy is reliant upon correct inhaler technique to allow for optimal deposition of medication.
